ヘリオスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/08/19 | 2,250 | 2,319 | 2,207 | 2,228 | -24 | -1.1% | 491,800 |
2021/08/18 | 2,284 | 2,302 | 2,162 | 2,252 | -26 | -1.1% | 670,000 |
2021/08/17 | 2,241 | 2,334 | 2,192 | 2,278 | +35 | +1.6% | 767,800 |
2021/08/16 | 2,122 | 2,296 | 2,095 | 2,243 | +83 | +3.8% | 1,067,900 |
2021/08/13 | 2,070 | 2,165 | 2,020 | 2,160 | +81 | +3.9% | 943,600 |
2021/08/12 | 1,965 | 2,086 | 1,945 | 2,079 | +64 | +3.2% | 1,259,200 |
2021/08/11 | 1,850 | 2,050 | 1,816 | 2,015 | +261 | +14.9% | 2,143,400 |
2021/08/10 | 1,818 | 1,855 | 1,698 | 1,754 | -48 | -2.7% | 784,000 |
2021/08/06 | 1,760 | 1,925 | 1,716 | 1,802 | +197 | +12.3% | 1,985,800 |
2021/08/05 | 1,622 | 1,644 | 1,593 | 1,605 | -13 | -0.8% | 63,500 |
2021/08/04 | 1,669 | 1,669 | 1,605 | 1,618 | -49 | -2.9% | 82,700 |
2021/08/03 | 1,660 | 1,685 | 1,659 | 1,667 | +11 | +0.7% | 70,800 |
2021/08/02 | 1,645 | 1,663 | 1,623 | 1,656 | +11 | +0.7% | 136,100 |
2021/07/30 | 1,655 | 1,658 | 1,623 | 1,645 | -13 | -0.8% | 147,000 |
2021/07/29 | 1,670 | 1,670 | 1,648 | 1,658 | -2 | -0.1% | 135,500 |
2021/07/28 | 1,700 | 1,709 | 1,657 | 1,660 | -51 | -3% | 145,500 |
2021/07/27 | 1,737 | 1,741 | 1,710 | 1,711 | -18 | -1% | 81,900 |
2021/07/26 | 1,755 | 1,761 | 1,708 | 1,729 | +9 | +0.5% | 110,500 |
2021/07/21 | 1,678 | 1,730 | 1,665 | 1,720 | +48 | +2.9% | 101,800 |
2021/07/20 | 1,638 | 1,681 | 1,633 | 1,672 | +20 | +1.2% | 89,600 |
2021/07/19 | 1,639 | 1,666 | 1,628 | 1,652 | -7 | -0.4% | 121,600 |
2021/07/16 | 1,671 | 1,689 | 1,645 | 1,659 | -22 | -1.3% | 139,400 |
2021/07/15 | 1,705 | 1,724 | 1,678 | 1,681 | -44 | -2.6% | 123,100 |
2021/07/14 | 1,690 | 1,729 | 1,689 | 1,725 | +31 | +1.8% | 108,400 |
2021/07/13 | 1,695 | 1,717 | 1,684 | 1,694 | -1 | -0.1% | 58,000 |
2021/07/12 | 1,685 | 1,715 | 1,663 | 1,695 | +50 | +3% | 113,400 |
2021/07/09 | 1,651 | 1,657 | 1,623 | 1,645 | -12 | -0.7% | 132,000 |
2021/07/08 | 1,720 | 1,725 | 1,657 | 1,657 | -73 | -4.2% | 146,800 |
2021/07/07 | 1,763 | 1,774 | 1,726 | 1,730 | -39 | -2.2% | 158,400 |
2021/07/06 | 1,779 | 1,801 | 1,755 | 1,769 | -15 | -0.8% | 125,400 |
2021/07/05 | 1,823 | 1,829 | 1,784 | 1,784 | -55 | -3% | 157,900 |
2021/07/02 | 1,890 | 1,890 | 1,839 | 1,839 | -69 | -3.6% | 180,000 |
2021/07/01 | 1,823 | 1,915 | 1,809 | 1,908 | +86 | +4.7% | 308,200 |
2021/06/30 | 1,815 | 1,851 | 1,790 | 1,822 | +4 | +0.2% | 150,600 |
2021/06/29 | 1,830 | 1,846 | 1,806 | 1,818 | -13 | -0.7% | 114,400 |
2021/06/28 | 1,813 | 1,849 | 1,804 | 1,831 | +18 | +1% | 103,300 |
2021/06/25 | 1,822 | 1,831 | 1,805 | 1,813 | -20 | -1.1% | 112,300 |
2021/06/24 | 1,815 | 1,837 | 1,806 | 1,833 | +8 | +0.4% | 83,300 |
2021/06/23 | 1,802 | 1,825 | 1,788 | 1,825 | +14 | +0.8% | 108,700 |
2021/06/22 | 1,786 | 1,811 | 1,765 | 1,811 | +25 | +1.4% | 88,700 |
2021/06/21 | 1,790 | 1,796 | 1,750 | 1,786 | -27 | -1.5% | 133,500 |
2021/06/18 | 1,779 | 1,826 | 1,769 | 1,813 | +34 | +1.9% | 130,000 |
2021/06/17 | 1,804 | 1,804 | 1,773 | 1,779 | -35 | -1.9% | 150,200 |
2021/06/16 | 1,805 | 1,817 | 1,785 | 1,814 | +2 | +0.1% | 120,700 |
2021/06/15 | 1,818 | 1,849 | 1,812 | 1,812 | -32 | -1.7% | 126,900 |
2021/06/14 | 1,843 | 1,874 | 1,817 | 1,844 | +4 | +0.2% | 179,100 |
2021/06/11 | 1,799 | 1,848 | 1,794 | 1,840 | +46 | +2.6% | 233,800 |
2021/06/10 | 1,785 | 1,834 | 1,769 | 1,794 | +22 | +1.2% | 315,900 |
2021/06/09 | 1,790 | 1,796 | 1,766 | 1,772 | -21 | -1.2% | 155,100 |
2021/06/08 | 1,804 | 1,804 | 1,768 | 1,793 | -11 | -0.6% | 168,600 |
801~
850
件表示中 / 2309件
類似銘柄と比較する
現在ご覧いただいている「ヘリオス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ヘリオス | 19,600円 | +395.9% | - | 0.00% | - | 5.45倍 |
|
iPS細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
ステムリム | 35,800円 | - | - | 0.00% | - | 2.91倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
大幸薬品 | 36,400円 | +11.1% | - | 0.00% | 33.21倍 | 2.26倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
オンコリス | 70,300円 | +58.7% | - | 0.00% | - | 12.39倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
Chordia | 24,900円 | - | - | 0.00% | - | 4.08倍 |
|
RNA制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
市場注目の銘柄
チャート関連のコラム